Analysis by Optimly for Optimly AI Visibility, in the Optimly AI Brand Index. This Business Profile tracks the Brand Authority Index and supporting AI visibility evidence. Last analyzed September 21, 2026.
Fauna Bio is an AI-driven drug discovery company leveraging genetic data from 100 million years of evolved disease resistance in diverse mammals. Using its exclusive biobank and in-house Convergence™ platform, the company identifies novel therapeutic targets and develops new drugs for human diseases such as obesity, cardiac regeneration, metabolic disorders, and conditions related to muscle preservation, pain tolerance, DNA damage, and fibrosis. They also research human health in space, focusing on preventing muscle/bone loss and protecting against radiation.
AI did not recommend this brand in the limited public category test.
Optimly has not yet published a supported competitor set for Faunabio.
Brand Authority Index (BAI) tier: Emerging (exact score locked for unclaimed brands)
Official website: https://faunabio.com/
Last analyzed: September 21, 2026
This Business Profile is published by Optimly in the Optimly AI Brand Index, a public research dataset showing how AI systems describe brands, categories, and competitors. Optimly AI Visibility analyzes sampled buyer-intent responses, cited sources, and public brand information. The Brand Authority Index summarizes answer presence, narrative accuracy, and owned citations where sufficient evidence is available.
If this is your brand, you can claim this profile to verify its contents and correct what AI models say about you: Claim this profile